Trump’s macho MAGA economy is a bust. But there are plenty of high-paying jobs for men—in nursing and teaching

U.S. blue-collar employment remains under pressure, with manufacturing and construction down roughly 150,000 jobs on an annual basis as of March, and manufacturing alone shedding 108,000 jobs in Trump’s first year back in office. By contrast, health care and social assistance continue to absorb labor, with registered nurses earning a median $93,600 versus $50,090 for production workers and 193,100 RN openings projected per year through 2032. The article argues that the workers Trump’s manufacturing agenda targets are bypassing faster-growing, better-paid sectors like nursing and teaching.

Analysis

The key market implication is not simply a labor mismatch, but a capital-allocation shift away from cyclical, capex-heavy employment toward structurally inelastic service demand. If blue-collar participation keeps fading while care roles absorb incremental labor, wage pressure will concentrate in labor-scarce healthcare niches rather than in manufacturing inputs, which is bearish for industrial staffing, staffing agencies tied to factories, and any “reshoring” trade premised on abundant labor. The second-order winner is not just hospitals; it is the labor-enablement stack around nursing, credentialing, recruiting, scheduling software, and outsourced clinical labor.

The political narrative may keep supporting policy optics for manufacturing, but earnings reality will likely diverge over a 12–24 month horizon. Companies exposed to hospital staffing, nursing education, and healthcare labor productivity should see more durable demand than industrial OEMs whose end-market volume is increasingly automated or delayed by labor scarcity. A weaker factory labor market also reduces the probability that tariff protection translates into broad domestic output gains; instead, it can raise input costs without restoring headcount, compressing margins for manufacturers with limited pricing power.

The contrarian read is that the market may be underpricing the persistence of this trend because it is cultural as much as economic. If even a modest share of prime-age men re-enters growth sectors like healthcare, the wage and staffing pressure there could be intense, but that is a multi-year social transition, not a near-term macro catalyst. Near term, the cleaner trade is to own beneficiaries of structural healthcare labor demand and fade names that need a manufacturing renaissance to justify valuations.

Key Decisions for Investors

• Long UNH / HCA on a 6-12 month horizon; both benefit from persistent healthcare labor demand and should outperform if blue-collar wage pressure stays contained while care demand remains durable.
• Long TTD? Actually avoid ad tech; better: long AMN or TASK if using public staffing proxies for healthcare labor tightness, but size small and use a 3-6 month window due to cyclicality and reimbursement risk.
• Short XLI vs long XLV as a 3-6 month pair trade; the manufacturing revival is losing credibility while healthcare labor demand is structurally supported, creating a cleaner relative-value expression.
• Avoid or underweight CAT, DE, and industrial automation names that rely on a broad cyclical re-acceleration in domestic factory employment; if automation accelerates, headcount recovery will not follow and order assumptions may prove too optimistic over 12-18 months.
• If looking for convexity, buy 6-9 month downside protection on small/mid-cap industrials with heavy domestic labor exposure; the thesis fails only if policy directly subsidizes labor-intensive reshoring, which appears low probability in the next two quarters.